共 126 条
[1]
HIV/AIDS Surveillance Report, 13, pp. 3-31, (2001)
[2]
Recommendations of the US Public Health Task Force on the use of zidovudine to reduce perinatal transmission of human immunodefiency virus, MMWR Morb. Mortal Wkly. Rep., 43, pp. 1-20, (1994)
[3]
Abrams E.J., Weedon J., Bertolli J., Et al., Aging cohort of perinatally human immunodefiency virus-infected children in New York City, Pediatr. Infect. Dis. J., 20, pp. 511-517, (2001)
[4]
Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial, Lancet, 353, pp. 1035-1039, (1999)
[5]
Stek A., Kramer F., Fassett M., Et al., The safety and efficacy of protease inhibitor therapy for HIV infection during pregnancy, Am. J. Obstet. Gynecol., 180, SUPPL. 7, (1999)
[6]
Guidelines for the use of antiretroviral agents in pediatric HIV infection, MMWR Morb. Mortal Wkly. Rep., 47, (1998)
[7]
Civitello L.A., Brouwers P., Pizzo P.A., Neurologic and neuropsychologic manifestations in 120 children with symptomatic HIV infection, Ann. Neurol., 34, (1993)
[8]
Belman A.L., Diamond G., Dickson D., Et al., Pediatric AIDS: Neurologic syndromes, Am. J. Dis. Child., 142, pp. 29-35, (1988)
[9]
England J.A., Baker C.J., Raskino C., Et al., Clinical and laboratory characteristics of a large cohort of symptomatic HIV-infected infants and children, Pediatr. Infect. Dis. J., 15, pp. 1025-1036, (1996)
[10]
Blanche S., Newell M., Mayaux M., Et al., Morbidity and mortality in European children vertically infected by HIV-1, J. Acquir. Immune Defic. Syndr. Flum. Retrovirol., 14, pp. 250-442, (1997)